STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Completed
- T-cell Acute Lymphoblastic Leukemia/Lymphoma
- CD7 CAR-T
- Yanda, Hebei, ChinaHebei yanda Ludaopei Hospital
2021-06-23
Jun 23, 2021F
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021i
Recruiting
- Relapsed/Refractory, High Risk Hematologic Malignancies
- T-ALL/Lymphoma
- CD7CAR T cells
- Langfang, Hebei, ChinaHebei Yanda Lu Daopei Hospital
2022-01-16
Jan 16, 2022S
Recruiting
- Pediatric ALL, B Cell
- Minimal Residual Disease
- Blinatumomab for Injection
- Seoul, Korea, Republic ofSeoul National University Hospital
2022-02-20
Feb 20, 2022S
Recruiting
- T-Cell Acute Lymphoblastic Leukemia
- Antigen-specific T cells CAR-T/CTL and DCvac
- Shenzhen, Guangdong, ChinaShenzhen Geno-immune Medical Institute
2022-03-14
Mar 14, 2022A
Not yet recruiting
- Acute Lymphoblastic Leukemia
- complete blood count
- (no location specified)
2022-02-15
Feb 15, 2022N
Not yet recruiting
- Acute Lymphoblastic Leukemia
- IMJ995 single agent
- (no location specified)
2022-02-17
Feb 17, 2022E
Recruiting
- Acute Myeloid Leukemia
- +2 more
- XmAb18968 - Dose level -1
- +4 more
- Milwaukee, WisconsinFroedtert Hospital & the Medical College of Wisconsin
2022-02-15
Feb 15, 2022G
Recruiting
- ALL, Recurrent, Adult
- Frankfurt (Main), Hessen, Germany
- +1 more
2022-01-06
Jan 6, 2022M
Active, not recruiting
- Leukemia
- Acute Lymphoblastic Leukemia
- gene-modified T cells targeted
- New York, New YorkMemorial Sloan Kettering Cancer Center
2022-02-01
Feb 1, 2022N
Not yet recruiting
- T-cell Acute Lymphoblastic Leukemia
- T-Cell Acute Lymphoblastic Lymphoma
- (no location specified)
2021-07-13
Jul 13, 2021G
Not yet recruiting
- Chemotherapy
- Leukemia, Acute Lymphoblastic
- (no location specified)
2022-03-23
Mar 23, 2022F
Recruiting
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- +2 more
- dasatinib plus consolidation chemotherapy with vincristine and prednisone
- dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
- Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xian Jiaotong University
2021-09-29
Sep 29, 2021i
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- +2 more
- CD7 CAR T cells
- Shenzhen, Guangdong, ChinaPeking University Shenzhen Hospital
2021-06-19
Jun 19, 2021P
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Inotuzumab Ozogamicin
- Bristol, United Kingdom
- +3 more
2022-01-27
Jan 27, 2022B
Recruiting
- T-Cell Acute Lymphoblastic Leukemia
- CD5 CART
- Beijing, Beijing, ChinaBeijing Boren Hospital
2022-03-16
Mar 16, 2022M
Recruiting
- T Acute Lymphoblastic Leukemia
- T-lymphoblastic Lymphoma
- RD13-01 cell infusion
- Langfang, Hebei, ChinaHebei Yanda Ludaopei Hospital
2020-11-03
Nov 3, 2020M
Not yet recruiting
- Acute Lymphoblastic Leukemia
- Leukemia
- Ponatinib
- +2 more
- Houston, TexasMD Anderson Cancer Center
2022-03-07
Mar 7, 2022A
Active, not recruiting
- Acute Lymphoblastic Leukemia, Adult B-Cell
- Blinatumomab Injection
- Paris, FranceHopital saint Louis
2021-04-30
Apr 30, 2021M
Completed
- Acute Lymphoblastic Leukemia
- Blinatumomab
- Hematopoietic Cell Transplantation
- Houston, TexasUniversity of Texas MD Anderson Cancer Center
2022-02-09
Feb 9, 20229
Recruiting
- B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoma
- anti-CD19 UCAR-T injection
- Kunming, Yunnan, China920th Hospital of Joint Logistics Support Force of People's Libe
2021-10-25
Oct 25, 2021S
Not yet recruiting
- T Lymphoblastic Leukemia/Lymphoma
- +4 more
- anti-CD7 CAR-T cells
- (no location specified)
2022-03-18
Mar 18, 2022S
Recruiting
- MRD-positive
- Acute Lymphoblastic Leukemia
- anti-CD19/CD22 CAR-T cells
- +2 more
- Shanghai, Shanghai, ChinaShanghai General Hospital
2021-09-23
Sep 23, 2021U
Recruiting
- Acute Lymphoblastic Leukemia
- Biospecimen Collection
- Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
2021-11-16
Nov 16, 2021i
Recruiting
- T-cell Acute Lymphoblastic Leukemia
- T-cell Non-Hodgkin Lymphoma
- anti-CD5 CAR T cells
- Shenzhen, Guangdong, ChinaPeking University Shenzhen Hospital
2021-02-27
Feb 27, 2021